Blocking or down-regulating the expression of Bcl-2 can promote the apoptosis of tumor cells and enhance the sensitivity of tumor cells to radiotherapy and chemotherapy, so as to improve the therapeutic effect of tumors [46,47]. Here, BCL2 is linked to neoplasm.